Epidemiology of Cancers: Bladder Cancer
Description
Transitional cell carcinomas (TCC) - In industrialized countries TCC account for over 90% of malignant tumours of the urinary bladder.
Nontransitional cell carcinomas - include squamous cell carcinomas, adenocarcinomas, and undifferentiated carcinomas and account for 5-7% of bladder cancers.
In developing countries an estimated 75% of cases are squamous cell carcinomas caused by infection with Schistosoma haematobium.
Symptoms
Haematuria (usually painless) - primary symptom of bladder cancer.
Frequent urination.
Dysuria.
Epidemiology
- The highest incidence rates are reported in North America and Western Europe and the lowest in Asia.
- In the UK bladder cancer is the 4th most common cancer among men. In 2002 of a total of 10,199 newly diagnosed cases of bladder cancer, 7,275 occurred among males compared with 2,924 among women giving a male to female ratio of 2.5:11.
- Moderate increases in incidence have been observed in industrialized countries in the last few decades2.
- In the UK age standardised incidence rates increased throughout the 1970s and 1980s reaching a peak in the late 1980s. Most of this increase occurred in older age groups especially among persons born before the 1920s1.
- Bladder cancer increases with increasing age with most cases occurring among persons aged over 50 years.
- In 2004 there were 4,816 deaths in the UK from bladder cancer. Age standardised mortality rates among men were 8.4/100,000 male compared with 2.9/100,000 among women. Over 90% of female deaths and 88% of male deaths occurred in persons aged over 65 years.
- Between 1992 and 2004 males rates of bladder cancer fell by 30% and was most marked in the 50-59 year age group.
- Population based survival rates increased from 40% in the early 1970s to 58-67% in the late 1980s. These increases have been most marked among men1.
- The five-year survival rates for persons with superficial tumours - 89-90%, compared with <50% with muscle invasive bladder cancer1.
Risk Factors
- Smoking - is the most important risk factor for the development of bladder cancer and is involved in the aetiology of an estimated 30-50% of bladder cancers.
- Age - increases significantly with age.
- Sex - 2-3 times more prevalent among males.
- Occupational exposure to industrial carcinogens, especially b-naphthylamine which was used in the manufacturing of dyes and the rubber industry in the 1950s.
- Cyclophosphamide and other chemotherapy drugs.
Screening and Prevention
No screening programme for bladder cancer is currently available in the UK.
Smoking cessation.
References
- Cancer Research UK.
- Adami, HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology, Oxford University Press: New York, 2002.
© CM Kirwan 2006